Wang Zichuan is a practicing lawyer, senior legal advisor and published author. Admitted to practice in February 2023, she previously served as in-house legal counsel and senior management executive at ATD, an internet medical enterprise, accumulating in-depth industry experience in the biopharmaceutical, healthcare and entertainment sectors. Boasting a multidisciplinary professional background, Ms. Wang is adept at combining corporate operational conditions and industry development trends to resolve complex legal and commercial issues throughout enterprises’ growth cycle. Her practice covers corporate governance, equity structure design, equity incentive arrangement, investment and financing, mergers and acquisitions, intellectual property protection and asset disposal, with customized legal solutions tailored to clients’ current operating status, future development strategies and practical demands. She specializes in assisting SMEs with compliance transformation and standardized operational management, regulating market competition behaviors, protecting corporate intangible assets, and supporting enterprises to leverage intellectual property rights to empower high-quality productivity development. Furthermore, she provides professional compliance guidance for high-tech enterprises concerning experimental ethics and normative management during the R&D of cutting-edge technologies and first-in-class patent innovations, and assists clients in establishing and improving management systems for core scientific research teams and technical talents.

Corporate governance, investment and financing, IPO, corporate restructuring, mergers and acquisitions, intellectual property protection and intellectual property financialization; Provides targeted legal services for high-tech enterprises engaged in biopharmaceuticals, medical healthcare, cultural entertainment, semiconductors, new energy and new materials

Member, Guangdong New Social Stratum Association
Member, Guangdong Writers Association & Guangdong Writers' Rights Protection Committee
Member, Shenzhen Intellectual Property Finance Association
Invited Mediator, Copyright Mediation Committee of Shenzhen Copyright Society

1. Assisted Chenghui Medical Co., Ltd. (Stock Code: 870856) in its listing on the National Equities Exchange and Quotations (NEEQ).
2. Provided professional legal consulting services for NAD+ patent pool planning for Munon Biotech.
3. Handled the patent licensing project of boron neutron drugs for Professor Lai Hongsen from Tufts University, USA.
4. Represented the client in a series of unfair competition disputes involving "Golden Buddha Thai Herbal Balm" and "Yingdi Thai Herbal Balm".
5. Represented Guangzhou Keyu Medical Aesthetics Hospital in multiple medical tort liability disputes.
6. Delivered specialized legal opinion services for the 2024 Annual General Meeting of Shareholders of Orange Interactive (Stock Code: 870110).
7. Served as long-term legal advisor for CIMC Transportation and its 13 subsidiaries, and conducted full-process investment and financing due diligence.
8. Provided professional legal consulting services for Zhongke Fenyang’s acquisition project of SanSanLing Semiconductor.
9. Conducted special due diligence and issued formal legal opinions on financial asset write-off matters for ShenZhongDian.
10. Handled complex construction engineering dispute cases involving Feiling Intelligent, Donghai Airlines, Yijian Construction, Tongda Electromechanical, Pangchuan and other enterprises.
11. Completed asset restructuring project due diligence for XinHaoyuan Co., Ltd. and Zhongqichen.